Skip to main content
SpringerLink
Log in

Prevention of post-menopausal bone loss with 1α-hydroxy vitamin D3 a three-year prospective study

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

An open and controlled prospective study was used to assess the preventive efficiency of 1α-hydroxy vitamin D3 (1α (OH) Vit. D3) on post-menopausal vertebral bone loss. Of the 36 patients included in the study, 25 completed two years of treatment with 1 μg/day of 1α (OH) Vit. D3 and 500 mg of calcium. The vertebral bone mineral density measured by dual photon absorptiometry did not vary in the treated group, whereas it decreased significantly in the control group at the end of the 2 years. At two years, withdrawal of treatment led to a signficant bone loss, whereas bone mass remained stable in a subgroup of patients who underwent a third year of treatment with 1α (OH) Vit. D3. Overall, tolerance was satisfactory. However, urinary calcium increased significantly during treatment and one third of the patients developed hypercalciuria ≥7.5 mmoles/24 h. No variation in either serum calcium or creatinine levels was noted. These results indicate that 1α (OH) Vit. D3 could be useful in preventing post-menopausal bone loss provided it was complemented by regular monitoring of urinary calcium excretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Riggs, B.L., Melton III, J. Involutional osteoporosis. N Engl J Med 1986, 314, 1676–1686.

    Article  CAS  PubMed  Google Scholar 

  2. Gallagher, J.C., Riggs, B.L., Eisman, J., Hamstra, A., Arnaud, S.B., Deluca, H.F., Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. Effect of age and dietary calcium. J Clin Invest 1979, 64, 729–736.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Riggs, B.L., Nelson, K.I. Effect of long-term treatment with calcitriol on calcium absorption and mineral metabolism in post-menopausal osteoporosis. J Clin Endocrinol Metab 1985, 61, 457–461.

    Article  CAS  PubMed  Google Scholar 

  4. Gallagher, J.C., Riggs, B.L., Action of 1,25-Dihydroxyvitamin D3 on calcium balance and bone turnover and its effects on vertebral fracture rate. Metabolism 1990, Suppl. I, 39, 30–34.

    Article  CAS  PubMed  Google Scholar 

  5. Caniggia, A., Nuti, R., Loré, F., Martini, G., Turchetti, V., Righi, G. Pathophysiological study in women with postmenopausal osteoporosis on long-term treatment with calcitriol. In: Osteoporosis: Physiological Basis, Assessment, and Treatment, Eds: DeLuca, H.F. Mazess, R.B. 1990, 201–212.

  6. Need, A.G., Nordin, C., Horowitz, M., Morris, H.A. Calcium and calcitriol therapy in osteoporotic postmenopausal women with impaired calcium absorption. Metabolism 1990, Suppl. I, 39, 53–54.

    Article  CAS  PubMed  Google Scholar 

  7. Heaney, R.P., Recker, R.R., Stegman, M.R., Moy, A.J.J. Calcium absorption in women: relationships to calcium intake, estrogen status, and age. J Bone Min Res 1989, 4, 469–475.

    Article  CAS  Google Scholar 

  8. Eastell, R., Yergey, A.L., Vieira, N.E., Cedel, S.L., Kumar, R., Riggs, B.L. Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-Dihydroxyvitamin D action. J Bone Min Res 1991, 6, 125–132.

    Article  CAS  Google Scholar 

  9. Epstein, S., Bryce, G., Hinman, J.W., Miller, O.N., Riggs, B.L., Hui, S.L., Johnston, C.C. The influence of age on bone mineral regulating hormones. Bone 1986, 7, 421–425.

    Article  CAS  PubMed  Google Scholar 

  10. Hartwell, D., Juel Riis, B., Christiansen, C. Changes in vitamin D metabolism during natural and medical menopause. Clin Endocrinol Metab 1990, 71, 127–132.

    Article  CAS  Google Scholar 

  11. Falch, J.A., Oftebro, H., Haug, E. Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25-hydroxy-vitamin D, 1,25-dihydroxyvitamin D, or vitamin D-binding-protein. J Clin Endocrinol Metab 1987, 64, 836–841.

    Article  CAS  PubMed  Google Scholar 

  12. Malluche, H.H., Faugere, M.C. Role of calcitriol in the management of osteoporosis. Metabolism 1990, Suppl. I, 39, 24–26.

    Article  CAS  PubMed  Google Scholar 

  13. Drezner, M.K., Nesbitt, T. Role of calcitriol in prevention of osteoporosis: Part I. Metabolism 1990, Suppl. 39, 180–23.

    Google Scholar 

  14. Geusens, P., Dequeker, J., Nijs, J., Verstraeten, A., Bramm, E. Prevention and treatment of osteopenia in the ovariectomized rat: effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisolone. Calcif Tissue Int 1991, 48, 127–137.

    Article  CAS  PubMed  Google Scholar 

  15. Pouilles, J.M., Trémollières, F., Louvet, J.P., Fournie, B., Morlock, G., Ribot, C. Sensitivity of dual-photon absorptiometry in spinal osteoporosis. Calcif Tissue Int 1988, 43, 329–334.

    Article  CAS  PubMed  Google Scholar 

  16. Christiansen, C., Christensen, M.S., McNair, P., Hagen, C., Stocklund, K.E., Transbol, I. Prevention of early postmenopausal bone loss. Controlled 2-year study in 315 normal females. Eur J Clin Invest 1980, 10, 273–279.

    Article  CAS  PubMed  Google Scholar 

  17. Christiansen, C., Christensen, M.S., Rodbro, P., Hagen, C., Transbol, I. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis. Eur J Clin Invest 1981, 11, 305–309.

    Article  CAS  PubMed  Google Scholar 

  18. Riis, B.J., Thomsen, K., Christiansen, C. Does vitamin 24R, 25 (OH)2D3 prevent postmenopausal bone loss? Calcif Tissue Int 1986, 39, 123–126.

    Article  Google Scholar 

  19. Sorensen, O.H., Andersen, R.B., Christensen, M.S., Friis, T., Hjorth, L., Jorgensen, F.S., Lund, B., Melsen, F., Mosekilde, L. Treatment of senile osteoporosis with 1α-hydroxyvitamin D3. Clin Endocrinol 1977, 7, Suppl., 169S-175S.

    Article  Google Scholar 

  20. Marshall, D.H., Nordin, B.E.C. The effect of 1α-hydroxyvitamin D3 with and without oestrogens on calcium balance in postmenopausal women. Clin Endocrinol 1977, 7, Suppl., 159s-168s.

    Article  Google Scholar 

  21. Hoikka, V., Alhava, E.M., Aro, A., Karjalaïnen, P., Rehnberg, V. Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium. Acta Med Scand 1980, 207, 221–224.

    Article  CAS  PubMed  Google Scholar 

  22. Lindholm, T.S., Nilsson, O.S., Kyhle, B.R., Elmstedt, E., Lindholm, T.C., Eriksson, S.A. Failures and complications in treatment of osteoporotic patients treated with 1α-hydroxyvitamin D3 supplemented by calcium. In: Osteoporosis, Eds.: Menczel J., et al. Chichester, John Wiley & Sons, 1982, 351–357.

    Google Scholar 

  23. Nordin, B.E.C., Horsman, A., Grilly, R.G., Marshall, D.H., Simpson, M. Treatment of spinal osteoporosis in postmenopausal women. Br Med J 1980, 280, 451–454.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Geusens, P., Dequeker, J. Long-term effect of nandrolone decanoate, 1α-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study. Bone Mineral 1986, 1, 347–357.

    CAS  PubMed  Google Scholar 

  25. Orimo, H., Shiraki, M., Hayashi, T., Nakamura, T. Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1α-hydroxyvitamin D3 Bone Mineral 1987, 3, 47–52.

    CAS  PubMed  Google Scholar 

  26. Fujita, T. Studies of osteoporosis in Japan. Metabolism 1990, 4, Suppl. 1, 39–42.

    Article  Google Scholar 

  27. Aloia, J.F., Vaswani, A., Yeh, J., Ellis, K., Yasumura, S., Cohn, S. Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 1988, 84, 401–408.

    Article  CAS  PubMed  Google Scholar 

  28. Gallagher, J.C., Godgar, D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitritiol. A randomized controlled study. Ann Int Med 1990, 113, 649–655.

    Article  CAS  PubMed  Google Scholar 

  29. Geusens, P., Vanderschueren, D., Verstraeten, A., Dequeker, J., Devos, P., Bouillon, R. Short-term course of 1,25 (OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis. Calcif Tissue Int 1991, 49, 168–173.

    Article  CAS  PubMed  Google Scholar 

  30. Ott, S.M., Chesnut, C.H. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Int Med 1989, 110, 267–274.

    Article  CAS  PubMed  Google Scholar 

  31. Ott, S.M., Chesnut, C.H. Tolerance to dose of calcitriol is associated with improved bone density in women with postmenopausal osteoporosis. J Bone Min Res 1990, Suppl. 2, S186.

    Google Scholar 

  32. Raisz, L.G. Direct effects of vitamin D and its metabolites on skeletal tissue. Clin Endocrinol Metab 1980, 9, 27–33.

    Article  CAS  PubMed  Google Scholar 

  33. Lund, B., Sorensen, O.H., Lund, B.J. 1α-hydroxycholecalciferol and renal function. Lancet ii 1978, 731.

    Article  Google Scholar 

  34. Verstraeten, A., Dequeker, J., Nijs, J., Geusens, P. Prevention of postmenopausal bone loss in rheumatoid arthritis patients. A two-year prospective study. Clin Exp Rheumatol 1989, 7, 351–358.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d'Endocrinologie- U.F., Maladies Osseuses et Métaboliques-CHU Purpan, 31059, Toulouse Cedex, France

    J. M. Pouilles, F. Tremollieres & C. Ribot

Authors
  1. J. M. Pouilles
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Tremollieres
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Ribot
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pouilles, J.M., Tremollieres, F. & Ribot, C. Prevention of post-menopausal bone loss with 1α-hydroxy vitamin D3 a three-year prospective study. Clin Rheumatol 11, 492–497 (1992). https://doi.org/10.1007/BF02283104

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02283104

Key words

Search

Navigation